Mazor Robotics (NASDAQ: MZOR) and Becton Dickinson and (NYSE:BDX) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, dividends and risk.
This table compares Mazor Robotics and Becton Dickinson and’s net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
|Becton Dickinson and
Becton Dickinson and pays an annual dividend of $3.00 per share and has a dividend yield of 1.4%. Mazor Robotics does not pay a dividend. Becton Dickinson and pays out 31.6% of its earnings in the form of a dividend. Becton Dickinson and has raised its dividend for 46 consecutive years.
This is a summary of recent ratings and recommmendations for Mazor Robotics and Becton Dickinson and, as provided by MarketBeat.
||Strong Buy Ratings
|Becton Dickinson and
Mazor Robotics currently has a consensus price target of $40.00, indicating a potential downside of 31.25%. Becton Dickinson and has a consensus price target of $239.21, indicating a potential upside of 11.00%. Given Becton Dickinson and’s stronger consensus rating and higher probable upside, analysts clearly believe Becton Dickinson and is more favorable than Mazor Robotics.
Risk and Volatility
Mazor Robotics has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, Becton Dickinson and has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500.
Insider & Institutional Ownership
24.1% of Mazor Robotics shares are held by institutional investors. Comparatively, 83.4% of Becton Dickinson and shares are held by institutional investors. 1.0% of Becton Dickinson and shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares Mazor Robotics and Becton Dickinson and’s revenue, earnings per share and valuation.
||Earnings Per Share
|Becton Dickinson and
Becton Dickinson and has higher revenue and earnings than Mazor Robotics. Mazor Robotics is trading at a lower price-to-earnings ratio than Becton Dickinson and, indicating that it is currently the more affordable of the two stocks.
Becton Dickinson and beats Mazor Robotics on 15 of the 18 factors compared between the two stocks.
About Mazor Robotics
Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. The company operates in the field of image guided surgery and computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness. It offers Mazor X surgical guidance system and Renaissance surgical guidance system that transform spine surgery from freehand procedures to guided procedures. The company was formerly known as Mazor Surgical Technologies Ltd. and changed its name to Mazor Robotics Ltd. in 2010. Mazor Robotics Ltd. was founded in 2000 and is based in Caesarea, Israel.
About Becton Dickinson and
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company’s BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.
Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.